Medium- and long-term recurrence after radioiodine therapy for differentiated thyroid carcinoma with recombinant human thyrotropin: a meta-analysis

IntroductionRadioactive iodine (RAI) is commonly used in the management of differentiated thyroid cancers (DTCs). However, the long-term efficacy and the risk of tumor recurrence associated with it remain unclear. In particular, the comparison between recombinant human thyrotropin (rhTSH) and thyroi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qixian Yao, Lili Song, Jun Xu, Zhongliang Wu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-12-01
coleção:	Frontiers in Endocrinology
Assuntos:	recombinant human thyroid stimulating hormone differentiated thyroid carcinoma long-term recurrence thyroid hormone withdrawal radioactive iodine
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1474121/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!